Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.

AUSTIN, Texas — Luminex Corporation (NASDAQ: LMNX) announced the completion of its acquisition of privately-held EraGen Biosciences, Inc., a Madison, Wisconsin based innovator in molecular diagnostic testing technologies for infectious disease and genetic applications, for $34 million in cash.

Luminex expects the EraGen acquisition will add between $5 million and $7 million to 2011 consolidated revenue. Read Wisconsin State Journal story here.